Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021

SELL
$29.75 - $37.99 $251,328 - $320,939
-8,448 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$27.5 - $38.19 $5,170 - $7,179
-188 Reduced 2.18%
8,448 $309,000
Q1 2021

May 04, 2021

BUY
$32.52 - $61.53 $6,113 - $11,567
188 Added 2.23%
8,636 $298,000
Q3 2020

Nov 05, 2020

BUY
$32.81 - $45.1 $277,178 - $381,004
8,448 New
8,448 $359,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $373M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.